《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2011年 > 3期

罗格列酮对肥胖糖尿病小鼠脂肪组织中Perilipin基因表达的影响

来自:中国糖尿病资讯网  编辑:admin|点击数:|2011-10-20

  ·糖尿病基础研究·

  晏益民 徐焱成 管晓峰 黄淑玉 徐文浩

  作者单位:432100湖北孝感市中心医院内分泌科(晏益民、管晓峰、黄淑玉、徐文浩);武汉大学中南医院内分泌科(徐焱成)

  【摘要】 目的 观察罗格列酮(RGZ)对肥胖糖尿病小鼠脂肪组织中脂滴包被蛋白(Perilipin)表达的影响,并探讨其作用机制。 方法 36只雄性C57BL/6小鼠随机分为对照(NC)组、糖尿病(DM)组及干预(RGZ)组,建立肥胖糖尿病小鼠模型,并应用 RT-PCR检测各组小鼠脂肪组织中Perilipin基因的表达水平。 结果 与NC组比较,DM组小鼠脂肪组织中Perilipin基因表达水平明显下调(P<0.01)。而经RGZ干预后,RGZ组小鼠脂肪组织中Perilipin基因表达水平明显高于DM组(P<0.01)。 结论 RGZ能上调肥胖糖尿病小鼠脂肪组织中Perilipin基因表达,并调节脂代谢紊乱及改善胰岛素抵抗。

  【关键词】脂滴包被蛋白;罗格列酮;过氧化物酶体增殖物激活受体;胰岛素抵抗;脂肪组织

  doi:10.3969/j.issn.1006-6187.2011.03.020

  Effects of rosiglitazone on the expression of perilipin mRNA in adipose tissue of obese diabetic mice

  YAN Yi-min, XU Yan-cheng, GUAN Xiao-feng, et al.Department of Endocrinology,Xiaogan Central Hospital,Hubei Xiaogan 432100,China

  【Abstract】 Objective To observe the effects of rosiglitazone on the expression of perilipin mRNA in adipose tissue of obese diabetic mice.

  Methods 36 male C57BL/6 mice were randomly divided into control (NC) group, diabetes mellitus (DM) group, and rosiglitazone intervention (RGZ) group. Then obese and diabetic mice model were established, and the expression levels of perilipin mRNA were detected by RT-PCR.

  Results The expression of perilipin mRNA in adipose tissue of mice was lower in DM group than in NC group [(0.48±0.12) vs (1.08±0.09), P<0.01] and was higher in RGZ group than in DM group [(0.81±0.10) vs (0.48±0.12), P<0.01]. Conclusions PPARγ agonist rosiglitazone may up-regulate the gene expression of perilipin in adipose tissue of obese diabetic mice, regulate lipid metabolism and improve insulin resistance.

  【Key words】Perilipin; Rosiglitazone; Peroxisome proliferator-activated receptor; Insulin resistance; Adipose tissue

上一篇:促性腺激素释放激素激动剂对In-R1-G9细胞中胰升血糖素表达的影响 下一篇:已经是最后一篇了